TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state

Leukemia

Volumn 20, Issue 2, 2006, Pages 280-285

  Herling, M ^a   Patel, K A ^a   Khalili, J ^a   Schlette, E ^a   Kobayashi, R ^a   Medeiros, L J ^a   Jones, D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CLL; Interluekin 4; Oncogenes; TCL1

Indexed keywords

INTERLEUKIN 4; ONCOPROTEIN; PROTEIN KINASE ZAP 70; T CELL LEUKEMIA 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHROMOSOME 11Q; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC HETEROGENEITY; GERMINAL CENTER; HISTOGENESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKEMIA CELL; MOLECULAR GENETICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 31444446831     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404017     Document Type: Article

References (21)

1. Brito-Babapulle V, Catovsky D. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 1991; 55: 1-9.
2. Virgilio L, Isobe M, Narducci MG, Carotenuto P, Camerini B, Kurosawa N et al. Chromosome walking on the TCL1 locus involved in T-cell neoplasia. Proc Natl Acad Sci USA 1993; 90: 9275-9279.
3. Virgilio L, Narducci MG, Isobe M, Billips LG, Cooper MD, Croce CM et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc Natl Acad Sci USA 1994; 91: 12530-12534.
4. Isobe M, Russo G, Haluska FG, Croce CM. Cloning of the gene encoding the delta subunit of the human T-cell receptor reveals its physical organization within the alpha-subunit locus and its involvement in chromosome translocations in T-cell malignancy. Proc Natl Acad Sci USA 1988; 11: 3933-3937.
5. Russo G, Isobe M, Gatti R, Finan J, Batuman O, Huebner K et al. Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient. Proc Natl Acad Sci USA 1989; 86: 602-606.
6. Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, Russo G et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci USA 1998; 95: 3885-3889.
7. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269-3274.
8. Soulier J, Pierron G, Vecchione D, Garand R, Brizard F, Sigaux F et al. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia. Genes Chromosomes Cancer 2001; 31: 248-254.
9. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004; 104: 328-335.
10. Narducci MG, Fiorenza MT, Kang SM, Bevilacqua A, Di Giacomo M, Remotti D et al. TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc Natl Acad Sci USA 2002; 99: 11712-11717.
11. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003; 101: 5007-5009.
12. Hoyer KK, Herling M, Bagrintseva K, Dawson DW, French SW, Renard M et al. T cell leukemia-1 modulates TCR signal strength and IFN-{gamma} levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation. J Immunol 2005; 175: 864-873.
13. Narducci MG, Pescarmona E, Lazzeri C, Signoretti S, Lavinia AM, Remotti D et al. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res 2000; 60: 2095-2100.
14. Nakayama I, Murao S, Kitazawa S, Azumi A, Yamamoto M, Maeda S. Activation of the TCL1 protein in B cell lymphomas. Pathol Int 2000; 50: 191-199.
15. Said JW, Hoyer KK, French SW, Rosenfelt L, Garcia-Lloret M, Koh PJ et al. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest 2001; 81: 555-564.
16. Roos J, Hennig I, Schwaller J, Zbaren J, Dummer R, Burg G et al. Expression of TCL1 in hematologic disorders. Pathobiology 2001; 69: 59-66.
17. Teitell M, Damore MA, Sulur GG, Turner DE, Stern MH, Said JW et al. TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. Proc Natl Acad Sci USA 1999; 96: 9809-9814.
18. Fink SR, Paternoster SF, Smoley SA, Flynn HC, Geyer SM, Shanafelt TD et al. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leuk Res 2005; 29: 253-262.
19. Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002; 99: 6955-6960.
20. Hoyer KK, French SW, Turner DE, Nguyen MT, Renard M, Malone CS et al. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci USA 2002; 99: 14392-14397.
21. Ottensmeier CH, Thompsett AR, Zhu D, Wilkins BS, Sweetenham JW, Stevenson FK. Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 1998; 91: 4292-4299.